ArticlePloS one2014
School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02975596 (Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Pooled it
- Role-specific household contact patterns in urban and rural China: Implications for influenza household transmission.Infectious Disease Modelling · 2027Article
- Estimating community-wide indirect effects of influenza vaccination: triangulation using mathematical models and bias analysis.American journal of epidemiology · 2025Article
- Parents and teachers' perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain.Human vaccines & immunotherapeutics · 2024Article
- Article
- Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017.Influenza and other respiratory viruses · 2022Article
- Article
- Observational
- Evaluating impact of school outreach vaccination programme in Hong Kong influenza season 2018 - 2019.Human vaccines & immunotherapeutics · 2020Article
- Understanding influenza vaccine perspectives and hesitancy in university students to promote increased vaccine uptake.Heliyon · 2019Article
- Improving Influenza Vaccination Coverage Among Patients With COPD: A Pilot Project.International journal of chronic obstructive pulmonary disease · 2019Article
- Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses.Human vaccines & immunotherapeutics · 2019Article
- Optimizing the impact of low-efficacy influenza vaccines.Proceedings of the National Academy of Sciences of the United States of America · 2018Article
- Estimating population effects of vaccination using large, routinely collected data.Statistics in medicine · 2018Article
- Linking influenza epidemic onsets to covariates at different scales using a dynamical model.PeerJ · 2018Article
- Article
- Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014-15.Emerging infectious diseases · 2016Article
Corrections and comments
- Commented on by
Authors and funding
21 authors at 5 institutions in 1 country.
Funding
Abstract
backgroundSchool-located influenza vaccination (SLIV) programs can substantially enhance the sub-optimal coverage achieved under existing delivery strategies. Randomized SLIV trials have shown these programs reduce laboratory-confirmed influenza among both vaccinated and unvaccinated children. This work explores the effectiveness of a SLIV program in reducing the community risk of influenza and influenza-like illness (ILI) associated emergency care visits.
methodsFor the 2011/12 and 2012/13 influenza seasons, we estimated age-group specific attack rates (AR) for ILI from routine surveillance and census data. Age-group specific SLIV program effectiveness was estimated as one minus the AR ratio for Alachua County versus two comparison regions: the 12 county region surrounding Alachua County, and all non-Alachua counties in Florida.
resultsVaccination of ∼50% of 5-17 year-olds in Alachua reduced their risk of ILI-associated visits, compared to the rest of Florida, by 79% (95% confidence interval: 70, 85) in 2011/12 and 71% (63, 77) in 2012/13. The greatest indirect effectiveness was observed among 0-4 year-olds, reducing AR by 89% (84, 93) in 2011/12 and 84% (79, 88) in 2012/13. Among all non-school age residents, the estimated indirect effectiveness was 60% (54, 65) and 36% (31, 41) for 2011/12 and 2012/13. The overall effectiveness among all age-groups was 65% (61, 70) and 46% (42, 50) for 2011/12 and 2012/13.
conclusionWider implementation of SLIV programs can significantly reduce the influenza-associated public health burden in communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.